390593
1-金刚烷乙胺 盐酸盐
99%
别名:
盐酸左氧氟沙星 盐酸盐
登录 查看组织和合同定价。
选择尺寸
关于此项目
经验公式（希尔记法）:
C12H21N · HCl
化学文摘社编号:
分子量:
215.76
NACRES:
NA.22
PubChem Substance ID:
UNSPSC Code:
12352100
MDL number:
Assay:
99%
InChI
1S/C12H21N.ClH/c1-8(13)12-5-9-2-10(6-12)4-11(3-9)7-12;/h8-11H,2-7,13H2,1H3;1H/t8?,9-,10+,11-,12-;
SMILES string
Cl.C[C@H](N)C12C[C@H]3C[C@H](C[C@H](C3)C1)C2
InChI key
OZBDFBJXRJWNAV-MZHJCFSPSA-N
assay
99%
mp
>300 °C (lit.)
functional group
amine
Quality Level
signalword
Warning
hcodes
Hazard Classifications
Acute Tox. 4 Oral - Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3
target_organs
Respiratory system
存储类别
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
dust mask type N95 (US), Eyeshields, Gloves
G G U Rohde
Der Internist, 52(9), 1047-1052 (2011-08-03)
Influenza infections have important socio-economic consequences. Risk groups identified so far include small children and elderly adults with comorbidities. In recent years in addition to seasonal influenza an outbreak of avian influenza occurred in 2005 and the new H1N1 pandemic
V G Belolipetskaia et al.
Eksperimental'naia i klinicheskaia farmakologiia, 74(7), 38-40 (2011-09-08)
Comparative pharmacokinetics of anti-influenza drug composition Antigrippin-maximum administered in capsules and a powder for preparing solutions has been studied after single administraton in a group of 18 healthy volunteers. Both preparations [manufactured by the Antiviral Research and Production Corporation (St
V S Smirnov et al.
Voprosy virusologii, 57(3), 23-27 (2012-08-22)
The purpose of the study was to evaluate the modulating effect of glutamyl-tryptophan (EW), glycyrrhizic acid (GA), and their combination on the course of experimental infection caused by influenza A (H3N2) virus in mice. The animals were infected with influenza
George Atiee et al.
Journal of clinical pharmacology, 52(9), 1410-1419 (2011-10-01)
Peramivir, an intravenously administered neuraminidase inhibitor, may be used concomitantly with other influenza antivirals. Two studies were conducted to assess the potential for pharmacokinetic interactions of peramivir when coadministered with oseltamivir or rimantadine. Twenty-one healthy subjects were enrolled in each
Georgina Cirrincione-Dall et al.
Journal of clinical pharmacology, 52(8), 1255-1264 (2011-11-01)
Preclinical data suggest increased antiviral activity and less viral resistance when neuraminidase inhibitors and adamantanes are used in combination to harness the complementary effects of their different mechanisms of action. Healthy volunteers were randomized to 5-day oral treatment with oseltamivir
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持